EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

MedFirst Healthcare Services lnc (4175) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of MedFirst Healthcare Services lnc TWD 64.57, price TWD 51.00, upside +26.6%, quality 59 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · TW · ISIN TW0004175005

MH Broad data Sep 24, 2026

MedFirst Healthcare Services lnc

4175 · TWO

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value 64.57 TWD · Undervalued (+27%)
!Quality 59/100
✓Healthy Growth (revenue 5y +6.2 %/yr)
!Thin margins · 1.6% net margin (TTM)
✓Moderate debt · generates free cash flow
·5.88% dividend yield
✓Ranks above peers (10/14)
!Narrow moat 41/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

138.53 TWD 49.74 TWD Fair Value 64.57 TWD Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 49.74 TWD – 138.53 TWD · fair‑value band 46.86 TWD – 85.71 TWD · the 51.00 TWD price screens below the 64.57 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow MedFirst Healthcare Services lnc in your weekly email

Every Wednesday you see whether MedFirst Healthcare Services lnc is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. The company offers diabetes care products, respiratory treatment, incontinence and wound dressing, medical devices, ostomy care, pain relief products, supplements, and rehabilitation products, as well as homecare, childcare, and maternal products.

Show more

MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. The company offers diabetes care products, respiratory treatment, incontinence and wound dressing, medical devices, ostomy care, pain relief products, supplements, and rehabilitation products, as well as homecare, childcare, and maternal products. The company also provides beauty care and oral hygiene products, daily essentials, medical books, cosmetics, and functional food and beverages, as well as wellness food and drugs. In addition, it offers fresh goods, home appliances, pre-orders, linen laundry services, and rental services, as well as prescription drug services. Further, the company is involved in the trade of medical supplies; sale of water electrolysis machine; foreign medical supplies; laundry products; brand agent distribution; and management of shopping malls. It sells products through its retail stores and online. MedFirst Healthcare Services, Inc. was founded in 1990 and is headquartered in Taoyuan City, Taiwan.

Stock analysis

MedFirst Healthcare Services lnc (4175) currently trades at 51.00 TWD, while our model-based Fair Value estimate is 64.57 TWD, implying the stock looks roughly 21.0% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 120.86 TWD per share, and 18 of the 26 models we run sit above the 51.00 TWD price.

Bear case: the Dividend Discount group reads lowest at 16.19 TWD, and 8 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 46.86 TWD (bear) to 85.71 TWD (bull), the price of 51.00 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

MedFirst Healthcare Services lnc reported revenue of 8.0B TWD in FY2025 versus 6.5B TWD in FY2021, a compound +5.2%/yr. Reported net income was 156M TWD in FY2025, compounding +23.0%/yr from FY2021.

Key figures

Market cap 2.2B TWD (≈ $67.8M) · P/E ratio 14.0 · P/S ratio 0.27 · EPS (TTM) 3.64 TWD · Dividend yield 5.9% · Net margin 1.9% · Return on equity 8.4% · Return on assets (EBIT) 2.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (medium confidence).

What moves the price

The share trades about 16% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at 27%, 4175 screens cheaper than that median.

Fair Value models

Bear 46.86 TWD Fair Value 64.57 TWD Bull 85.71 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.4699 TWD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 118.95 TWD 165.94 TWD 223.17 TWD 81
Growth DCF 119.56 TWD 160.65 TWD 207.92 TWD 80
Owner Earnings 125.06 TWD 174.26 TWD 234.16 TWD 77
All 26 models by family
DCF Models
FCF DCF 118.95 TWD 165.94 TWD 223.17 TWD 81
Owner Earnings 125.06 TWD 174.26 TWD 234.16 TWD 77
5Y Revenue Exit 69.65 TWD 95.56 TWD 126.03 TWD 73
5Y EBITDA Exit 157.71 TWD 257.28 TWD 371.24 TWD 75
5Y P/E Exit 74.24 TWD 103.99 TWD 133.51 TWD 72
10Y Revenue Exit 89.65 TWD 115.91 TWD 146.95 TWD 68
10Y EBITDA Exit 138.37 TWD 210.94 TWD 304.13 TWD 68
10Y P/E Exit 93.13 TWD 120.86 TWD 151.74 TWD 65
Earnings-Based
Graham-Dodd 24.99 TWD 71.51 TWD 94.27 TWD 65
Lynch FV 14.66 TWD 20.95 TWD 27.23 TWD 61
PEG = 1.0 14.66 TWD 20.95 TWD 27.23 TWD 57
EPV 19.91 TWD 23.73 TWD 26.82 TWD 74
Dividend Discount
Gordon GGM 11.14 TWD 18.67 TWD 24.23 TWD 68
DDM Multi-Stage 11.14 TWD 16.19 TWD 20.08 TWD 67
Multiples
P/E Multiple 57.88 TWD 77.17 TWD 96.47 TWD 63
P/S Multiple 46.86 TWD 62.47 TWD 78.09 TWD 58
P/B Multiple 46.86 TWD 62.47 TWD 78.09 TWD 55
EV/EBIT 51.58 TWD 72.73 TWD 93.88 TWD 65
EV/EBITDA 216.39 TWD 292.47 TWD 368.56 TWD 67
EV/Revenue 33.42 TWD 52.83 TWD 72.23 TWD 53
Asset-Based
NCAV (Graham) 18.42 TWD 24.69 TWD 36.85 TWD 54
Growth DCF
Growth DCF 119.56 TWD 160.65 TWD 207.92 TWD 80
Rev-Margin DCF 69.65 TWD 98.06 TWD 131.00 TWD 73
Economic Profit
Residual Income 29.20 TWD 31.20 TWD 34.21 TWD 76
ROIC Compounder 19.91 TWD 23.73 TWD 26.82 TWD 72
Growth Earnings
Growth-Adj P/E 46.53 TWD 66.47 TWD 86.40 TWD 67

Open the full fair value analysis →

Notify me when 4175 reaches fair value

Put 4175 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 59/100

Of which business quality 56 · Market factors (momentum, volatility) 47

Profitability 48
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 62
Earnings quality: real cash, not paper profit
Fin. Strength 28
Balance sheet, leverage, solvency risk
Investment 90
Disciplined investing over empire-building
Low Volatility 99
Calm price path (market factor)
Momentum 31
Price trend over the last 3–12 months (market factor)
52W Momentum 13
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 67/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+3.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.0%
What shareholders gained per year (last 5 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+6.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.9%
Dividend (yield on the price)5.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 3%
2025 sits 123% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−16.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about −18.1% a year for the price.

Watch 4175, get fair value alerts →

Compare MedFirst Healthcare Services lnc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 61 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 59 · Top 25%
Fair Value upside +25% · Above median
Profitability
Return on equity (TTM) 8% · Above median
Return on assets 2% · Above median
Net margin (TTM) 2% · Above median
Operating margin (TTM) 2% · Below median
Growth and dividend
Revenue growth −1% · Below median
Dividend yield (TTM) 5.9% · Top 25%
Balance sheet
Debt / equity 0.58× · Highest 25%

Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper

P/E (TTM) 14.0× · Cheapest 25%
P/B 1.40× · Cheaper than median
P/S (TTM) 0.27× · Cheaper than median
P/FCF 0.1× · Cheapest 25%
EV/EBITDA 7.3× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)69 · sector 33
FUTURE (revenue growth)0 · sector 19
PAST (return on equity)34 · sector 22
HEALTH (low debt)71 · sector 96
DIVIDEND (yield)100 · sector 64

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Alibaba Health Information Technology Limited 0241 HK$2.84 HK$2.03 −28%
Yifeng Pharmacy Chain Co 603939 ¥22.09 ¥40.59 +84%
DaShenLin Pharmaceutical Group 603233 ¥17.97 ¥26.45 +47%
LBX Pharmacy Chain Joint Stock Company 603883 ¥12.90 ¥14.19 +10%
MedPlus Health Services Limited MEDPLUS ₹662.00 ₹393.38 −41%
Yixintang Pharmaceutical Group 002727 ¥10.96 ¥9.51 −13%
Anhui Huaren Health Pharmaceutical Co 301408 ¥15.56 ¥17.12 +10%
ShuYu Civilian Pharmacy Corp 301017 ¥12.95 ¥5.91 −54%
Apotea AB APOTEA kr 81.90 kr 46.46 −43%
Luyan Pharma Co 002788 ¥11.24 ¥15.91 +42%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "MedFirst Healthcare Services lnc Fair Value". https://www.fairvalue-calculator.com/stock/4175

Frequently asked questions

Is MedFirst Healthcare Services lnc (4175) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 64.57 TWD versus a price of 51.00 TWD, about +27% upside (undervalued).
What is the fair value of 4175?
Our model-based fair value for MedFirst Healthcare Services lnc is 64.57 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 51.00 TWD.
What is the quality score of 4175?
MedFirst Healthcare Services lnc has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MedFirst Healthcare Services lnc (4175)?
Our model-based price target is the fair value of 64.57 TWD (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 46.86 TWD, optimistic scenario 85.71 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the MedFirst Healthcare Services lnc stock forecast for 2026?
Our models put fair value at 64.57 TWD, about +27% upside versus a price of 51.00 TWD (undervalued). Cautious scenario 46.86 TWD, optimistic scenario 85.71 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of MedFirst Healthcare Services lnc (4175)?
MedFirst Healthcare Services lnc reported trailing-twelve-month revenue of about 8.0B TWD (latest available figure, as of Sep 24, 2026).
Does MedFirst Healthcare Services lnc pay a dividend?
MedFirst Healthcare Services lnc currently shows a dividend yield of about 5.88% relative to its recent price (as of Sep 24, 2026).
What growth is priced into MedFirst Healthcare Services lnc (4175)?
For today's price to be fair in a discounted-cash-flow model, MedFirst Healthcare Services lnc would have to grow free cash flow by -16.8 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 4175 use?
Our models discount MedFirst Healthcare Services lnc at 11.8 %: a base by market capitalisation (micro), damped by beta 0.16, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For MedFirst Healthcare Services lnc that is -16.8 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has MedFirst Healthcare Services lnc (4175) delivered so far?
Over the past 5 years revenue at MedFirst Healthcare Services lnc grew +6.2 % a year. The price currently implies -16.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of MedFirst Healthcare Services lnc (4175) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into MedFirst Healthcare Services lnc (-16.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of MedFirst Healthcare Services lnc (4175)?
The free-cash-flow yield on the price is 28.93 %: that much free cash flow MedFirst Healthcare Services lnc produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of MedFirst Healthcare Services lnc (4175)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MedFirst Healthcare Services lnc it is 64.57 TWD per share (as of Sep 24, 2026), against a price of 51.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is MedFirst Healthcare Services lnc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 4175 trades below its calculated fair value: price 51.00 TWD, fair value 64.57 TWD, a gap of about +27% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4175?
No. The price is what the market pays today (51.00 TWD); the fair value is what the company's own numbers justify (64.57 TWD). For MedFirst Healthcare Services lnc the two are 13.57 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is MedFirst Healthcare Services lnc worth?
The market values MedFirst Healthcare Services lnc at about 2.2B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 51.00 TWD; our models calculate a fair value of 64.57 TWD per share.
What do the bullish and bearish scenarios say about 4175?
Our models span a range for MedFirst Healthcare Services lnc: cautious scenario 46.86 TWD, base 64.57 TWD, optimistic 85.71 TWD per share (as of Sep 24, 2026, price 51.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4175?
MedFirst Healthcare Services lnc trades at a price-to-earnings ratio of 14.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 64.57 TWD is built from several models across several years. Other multiples: P/B 1.4, P/S 0.3, EV/EBITDA 7.3.
How solid is the balance sheet of MedFirst Healthcare Services lnc (4175)?
Balance-sheet figures for MedFirst Healthcare Services lnc (as of Sep 24, 2026): return on equity 8.4%, debt of 0.58 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is 4175 from its 52-week high?
MedFirst Healthcare Services lnc trades at 51.00 TWD, about 16% below its 52-week high of 60.50 TWD and 3% above the low of 49.74 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 64.57 TWD is for.
Which stocks are comparable to MedFirst Healthcare Services lnc?
From the same area (Healthcare) we also value Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, LBX Pharmacy Chain Joint Stock Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MedFirst Healthcare Services lnc stock attractive at the current price?
The data as of Sep 24, 2026: price 51.00 TWD, calculated fair value 64.57 TWD (+27%), Quality Score 59/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4175 calculated?
We run MedFirst Healthcare Services lnc through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 64.57 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. MedFirst Healthcare Services lnc currently trades 27 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MedFirst Healthcare Services lnc (4175)?
The closing price on Sep 24, 2026 was 51.00 TWD. Our model-based fair value is 64.57 TWD, about +27% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MedFirst Healthcare Services lnc right now?
Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (46.86 TWD to 85.71 TWD) leaves room in how you read the outcome.

Key figures of MedFirst Healthcare Services lnc

How large is the market capitalisation of MedFirst Healthcare Services lnc (4175)?
The market capitalisation of MedFirst Healthcare Services lnc is 2.2B TWD (≈ $67.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MedFirst Healthcare Services lnc (4175)?
The price-to-sales ratio of MedFirst Healthcare Services lnc is 0.27 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MedFirst Healthcare Services lnc (4175)?
Earnings per share at MedFirst Healthcare Services lnc are 3.64 TWD (price ÷ EPS = P/E 14.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MedFirst Healthcare Services lnc (4175)?
The dividend yield of MedFirst Healthcare Services lnc is 5.9% (payout 82.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MedFirst Healthcare Services lnc (4175)?
The net margin of MedFirst Healthcare Services lnc is 1.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MedFirst Healthcare Services lnc (4175)?
The return on equity (ROE) of MedFirst Healthcare Services lnc is 8.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MedFirst Healthcare Services lnc (4175)?
On an EBIT basis the return on assets of MedFirst Healthcare Services lnc is 2.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MedFirst Healthcare Services lnc (4175)?
The operating margin of MedFirst Healthcare Services lnc is 1.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MedFirst Healthcare Services lnc (4175)?
Revenue at MedFirst Healthcare Services lnc is growing −0.7% versus a year earlier (3y avg +3.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MedFirst Healthcare Services lnc (4175)?
Earnings per share at MedFirst Healthcare Services lnc are growing −58.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does MedFirst Healthcare Services lnc (4175) carry?
The net debt of MedFirst Healthcare Services lnc is 847M TWD (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch MedFirst Healthcare Services lnc in the live analysis

One click puts MedFirst Healthcare Services lnc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.